Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3406]
News [7759]
Articles [63]
Editorials [9]
Conferences [207]
elearning [49]
Randomized Phase II Study in Patients with HER2-Positive Breast Cancer
Dr Luca Gianni - Ospedale San Raffaele, Milan, Italy
Randomized Phase II Study in Patients with HER2-Positive Breast Cancer ( Dr Luca Gianni - Ospedale San Raffaele, Milan, Italy )
16 Dec 2011
Anaemia management update: blood transfusion and ESA use in oncology
Prof Matti Aapro, Prof Valeria Santini, Dr Joachim Fandrey, Dr Richard Delarue...
Anaemia management update: blood transfusion and ESA use in oncology ( Prof Matti Aapro, Prof Valeria Santini, Dr Joachim Fandrey, Dr Richard Delarue and Prof Donat Spahn )
15 Dec 2011
Novel agents and proteasome inhibitors in myeloma
Prof Michele Cavo - University of Bologna, Italy
Novel agents and proteasome inhibitors in myeloma ( Prof Michele Cavo - University of Bologna, Italy )
14 Dec 2011
Advances in peripheral T-cell lymphoma
Prof John Gribben – Barts and The London Trust, London and Prof Bertrand...
Advances in peripheral T-cell lymphoma ( Prof John Gribben – Barts and The London Trust, London and Prof Bertrand Coiffier - Hospices Civils de Lyon, France )
14 Dec 2011
Translational research and proteasome inhibitors in multiple myeloma
Prof Kenneth Anderson - Dana-Farber Cancer Institute, Boston, USA
Translational research and proteasome inhibitors in multiple myeloma ( Prof Kenneth Anderson - Dana-Farber Cancer Institute, Boston, USA )
14 Dec 2011
CLEOPATRA trial to evaluate the efficacy and safety of pertuzumab + trastuzumab...
Prof Jose Baselga - Massachusetts General Hospital Cancer Center, Boston, MA
CLEOPATRA trial to evaluate the efficacy and safety of pertuzumab + trastuzumab + docetaxel ( Prof Jose Baselga - Massachusetts General Hospital Cancer Center, Boston, MA )
14 Dec 2011
Developments in proteasome inhibitors, transplant and myeloma research
Dr Keith Stewart - Mayo Clinic, Scottsdale Arizona, USA
Developments in proteasome inhibitors, transplant and myeloma research ( Dr Keith Stewart - Mayo Clinic, Scottsdale Arizona, USA )
14 Dec 2011
GIMEMA study compares bortezomib-thalidomide-dexamethasone with thalidomide...
Prof Michele Cavo - University of Bologna, Italy
GIMEMA study compares bortezomib-thalidomide-dexamethasone with thalidomide-dexamethasone prior to double autologous stem-cell transplantation ( Prof Michele Cavo - University of Bologna, Italy )
13 Dec 2011
Lenalidomide with melphalan + prednisone and lenalidomide maintenance for...
Prof Antonio Palumbo - University of Torino, Italy
Lenalidomide with melphalan + prednisone and lenalidomide maintenance for multiple myeloma ( Prof Antonio Palumbo - University of Torino, Italy )
13 Dec 2011
Evolving treatment options in castration-resistant prostate cancer
Prof Kurt Miller, Dr Eleni Efstathiou, Dr Karim Fizazi and Dr Göran Ahlgren
Evolving treatment options in castration-resistant prostate cancer ( Prof Kurt Miller, Dr Eleni Efstathiou, Dr Karim Fizazi and Dr Göran Ahlgren )
6 Dec 2011
Advances in the treatment of T-cell lymphoma
Prof John Gribben, Dr Myron Czuczman, Dr Randy Gascoyne, Prof Michael...
Advances in the treatment of T-cell lymphoma ( Prof John Gribben, Dr Myron Czuczman, Dr Randy Gascoyne, Prof Michael Pfreundschuh and Prof Wyndham Wilson )
6 Dec 2011
Key research from the 9th International Workshop for Lymphoma
Professor John Gribben, Dr Myron Czuczman, Dr Randy Gascoyne, Professor Michael...
Key research from the 9th International Workshop for Lymphoma ( Professor John Gribben, Dr Myron Czuczman, Dr Randy Gascoyne, Professor Michael Pfreundschuh and Prof Wyndham Wilson )
6 Dec 2011

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation